Serostim Sales Plan Included Physician Kickbacks, Government Alleges
Executive Summary
Serono sales managers created a plan offering physicians financial incentives to prescribe Serostim in numbers needed to achieve sales goals, an information filed by Boston U.S. Attorney Michael Sullivan alleges
You may also be interested in...
Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case
Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing
Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case
Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing
Serono Nears Settlement In Serostim Investigation, Sets Aside $725 Mil.
Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)